Compounds > dextrothyroxine
Page last updated: 2024-08-20

dextrothyroxine and paclitaxel

dextrothyroxine has been researched along with paclitaxel in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huisman, MT; Schinkel, AH; Smit, JW; van Tellingen, O; Wiltshire, HR1
Borst, P; Sarkadi, B; Smith, AJ; Szabo, K; Szakacs, G; van Helvoort, A; van Meer, G; Varadi, A; Welker, E1
Drinyaev, VA; Ermakova, NV; Korystov, YN; Kruglyak, EB; Kublik, LN; Levitman, MKh; Mosin, VA; Novik, TS; Shaposhnikova, VV; Sterlina, TS1
Ashraf, S; Beech, RN; Hancock, MA; Prichard, RK1
Copeland, NG; Hanash, SM; Hashimoto, K; Jenkins, NA; Katayama, H; Kimura, T; Kobayashi, M; Kodama, M; Kodama, T; Mabuchi, S; Newberg, JY; Rangel, R; Sawada, K; Tien, JC; Wei, Z; Yoshihara, K1

Other Studies

5 other study(ies) available for dextrothyroxine and paclitaxel

ArticleYear
Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.
    The Journal of clinical investigation, 1999, Volume: 104, Issue:10

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbon Radioisotopes; Crosses, Genetic; Digoxin; Female; Heterozygote; Insecticides; Ivermectin; Male; Maternal-Fetal Exchange; Mice; Mice, Knockout; Mice, Mutant Strains; Paclitaxel; Placenta; Pregnancy; Saquinavir; Tissue Distribution

1999
MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.
    The Journal of biological chemistry, 2000, Aug-04, Volume: 275, Issue:31

    Topics: Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Biological Transport; Cell Polarity; Cells, Cultured; Cyclosporine; Cyclosporins; Cytotoxins; Daunorubicin; Digoxin; Epithelial Cells; Humans; Ivermectin; Kidney; Paclitaxel; Pharmaceutical Preparations; Phosphatidylcholines; Recombinant Proteins; Spodoptera; Swine; Verapamil; Vinblastine

2000
Avermectins inhibit multidrug resistance of tumor cells.
    European journal of pharmacology, 2004, Jun-16, Volume: 493, Issue:1-3

    Topics: Animals; Cell Division; Cell Line, Tumor; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Synergism; Fluoresceins; Fluorescence; Humans; Ivermectin; Leukemia P388; Male; Mice; Paclitaxel; Rhodamine 123; Russia; Vincristine

2004
Ivermectin binds to Haemonchus contortus tubulins and promotes stability of microtubules.
    International journal for parasitology, 2015, Volume: 45, Issue:9-10

    Topics: Animals; Antiparasitic Agents; Binding Sites; Cloning, Molecular; Haemonchus; Ivermectin; Microtubules; Models, Molecular; Paclitaxel; Protein Binding; Protein Conformation; Tubulin

2015
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 08-29, Volume: 114, Issue:35

    Topics: Apoptosis; beta Karyopherins; Carcinoma, Ovarian Epithelial; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Humans; Ivermectin; Loss of Function Mutation; Neoplasms, Glandular and Epithelial; Oncogenes; Ovarian Neoplasms; Paclitaxel; RNA, Small Interfering

2017